<DOC>
	<DOCNO>NCT02949154</DOCNO>
	<brief_summary>A retrospective study investigate relationship FDG-PET uptake LDH level .</brief_summary>
	<brief_title>Elevated LDH Serum Levels FDG-PET Metastatic Melanoma Patients</brief_title>
	<detailed_description>Patient characteristic , tumour characteristic include BRAF mutation status baseline serum S100B LDH level patient retrospectively determined electronical patient file . In patient , tumour burden 18F-FDG uptake tumour lesion measure use multiple standard quantification parameter baseline 18F-FDG-PET scan . Tumour burden also measure baseline contrast enhance CT scan . The correlation FDG-PET parameter baseline LDH S100B level , respectively , analyze use univariate multivariate regression analysis .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>All patient &gt; 18 year histologically proven metastatic melanoma ( American Joint Committee Cancer [ AJCC ] stage IV melanoma ) treat UMCG May 2014 December 2015. participation interventional study miss baseline 18FFDG PET scan and/or baseline contrast enhance CT scan miss baseline serum LDH level miss BRAF mutation status , concurrent malignancy history previous malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>